PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer
Open Access
- 3 December 2019
- Vol. 11 (12), 1923
- https://doi.org/10.3390/cancers11121923
Abstract
Although gastric cancer is a common cause of cancer mortality worldwide, its biological heterogeneity limits the available therapeutic options. Therefore, identifying novel therapeutic targets for developing effective targeted therapy of gastric cancer is a pressing need. Here, we investigate molecular function and regulatory mechanisms of Vestigial-like 1 (VGLL1) in gastric cancer. Microarray analysis of 556 gastric cancer tissues revealed that VGLL1 was a prognostic biomarker that correlated with PI3KCA and PI3KCB. VGLL1 regulates the proliferation of gastric cancer cells, as shown in live cell imaging, sphere formation, and in vivo xenograft model. Tail vein injection of NUGC3 cells expressing shVGLL1 resulted in less lung metastasis occurring when compared to the control. In contrast, larger metastatic lesions in lung and liver were detected in the VGLL1-overexpressing NUGC3 cell xenograft excision mouse model. Importantly, VGLL1 expression is transcriptionally regulated by the PI3K-AKT-β-catenin pathway. Subsequently, MMP9, a key molecule in gastric cancer, was explored as one of target genes that were transcribed by VGLL1-TEAD4 complex, a component of the transcription factor. Taken together, PI3K/AKT/β-catenin signaling regulates the transcription of VGLL1, which promotes the proliferation and metastasis in gastric cancer. This finding suggests VGLL1 as a novel prognostic biomarker and a potential therapeutic target.Funding Information
- National Research Foundation of Korea (NRF-2017R1A2B2011936, NRF-2018R1A5A2023127, NRF-2019R1A2C1087492)
- Ministry of Health and Welfare (HI13C2162)
- Korea Research Institute of Bioscience and Biotechnology (KGM4751713)
This publication has 37 references indexed in Scilit:
- Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancerCarcinogenesis: Integrative Cancer Research, 2013
- HER2-positive gastric cancerGastric Cancer, 2013
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainProceedings of the National Academy of Sciences of the United States of America, 2012
- Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?Therapeutic Advances in Gastroenterology, 2012
- Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD ComplexesStructure, 2012
- Diminished metastasis in tetraspanin CD151–knockout miceBlood, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Mutant PIK3CA promotes cell growth and invasion of human cancer cellsCancer Cell, 2005
- Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell typesBiotechnology & Bioengineering, 2003